Clinical Trial Update: Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial completed evaluating optimal anticoagulation strategies for higher-risk patients following catheter ablation for atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Atrial Fibrillation, Stroke | Phase 4 | Status: COMPLETED